Form 4: Aspira Women's Health Director Converts Restricted Stock Units to Common Shares
Insider Transaction Report
Aspira Women's Health Inc. Director Stefanie L. Cavanaugh has converted 5,937 restricted stock units (RSUs) into common stock following their vesting on June 4, 2025.
Summary
- Stefanie L. Cavanaugh, a Director at Aspira Women's Health Inc. (AWHL), reported a change in beneficial ownership.
- On June 4, 2025, 5,937 restricted stock units (RSUs) granted to Ms. Cavanaugh vested and were converted into an equal number of common shares.
- These RSUs were part of a larger grant of 23,750 RSUs awarded on August 22, 2024.
- Following this transaction, Ms. Cavanaugh beneficially owns a total of 78,726 shares of Aspira Women's Health Inc. common stock.
- The conversion occurred at a price of $0, as it represents the vesting of previously granted equity awards.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. It's a routine insider transaction (RSU vesting) which is an expected part of executive compensation. The conversion to common stock increases the director's direct ownership, which can be seen as a positive alignment of interests, but it's not a new investment.
Positives
- The vesting and conversion of restricted stock units indicate a pre-scheduled compensation event for the director, aligning her interests with shareholders.
- An increase in direct common stock ownership by a director can signal confidence in the company's long-term prospects.
Future Outlook
This Form 4 filing pertains to a routine insider transaction and does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.
Industry Context
This filing is a standard disclosure of an insider's change in beneficial ownership, common across all publicly traded companies. It reflects a pre-scheduled equity compensation event for a director within the healthcare diagnostics industry, specifically women's health.
Stakeholder Impact
- Shareholders: The conversion of RSUs into common stock results in a minor increase in the outstanding share count, which is a routine and expected part of equity compensation plans. It also signals continued alignment of director interests with shareholders.
Key Dates
| Date | Description |
|---|---|
| 08/22/2024 | Date when Stefanie L. Cavanaugh was granted 23,750 Restricted Stock Units (RSUs). |
| 06/04/2025 | Date when 5,937 RSUs vested and were converted into common stock. |
| 06/05/2025 | Date the Form 4 filing was signed and submitted. |
Keywords
Aspira Women's Health, AWHL, Form 4, Insider Transaction, Restricted Stock Units, RSU Vesting, Common Stock, Director Ownership, Equity Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.